Aequus Pharmaceuticals Inc.
AQSZF
Get informed when a big investor buys or sells
+ FollowMarket Cap$26.53K
Close$
Share Statistics
| Market cap | $26,527.00 |
|---|---|
| Enterprise Value | $4.35 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.02 |
| Beta | -0.21 |
| Outstanding Shares | 132,634,431 |
Return
| Return on Equity | 9.52% |
|---|---|
| Return on Assets | -334.60% |
| Return on Invested Capital | 7.34% |
Valuation & Multiples
| P/E Ratio | 3.13 |
|---|---|
| PEG | -1.95 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | 4.73 |
| Enterprise Value to EBIT | -8.58 |
| Enterprise Value to Net Income | -7 |
| Total Debt to Enterprise | 1 |
| Debt to Equity | -0.63 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
October 13, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Aequus Pharmaceuticals Inc.
12 employees
CEO: Douglas Glen Janzen Aequus Pharmaceuticals Inc. is a specialized pharmaceutical firm based in Vancouver, Canada, dedicated to the development and commercialization of medicinal products across the country. The company concentrates its efforts on several key...